血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2020 国际建议：获得性血友病A的诊断和治疗

2020-05-07 国外血液科相关专家小组 Haematologica. 2020 May 7.

血友病

获得性血友病A（AHA）是由抗凝血因子VIII(FVIII)自身抗体中和引起的一种罕见的出血性疾病。本文主要针对AHA的诊断和治疗的相关内容提出指导建议。

中文标题：

2020 国际建议：获得性血友病A的诊断和治疗

英文标题：

International recommendations on the diagnosis and treatment of acquired hemophilia A.

发布机构：

国外血液科相关专家小组

发布日期：

2020-05-07

简要介绍：

获得性血友病A（AHA）是由抗凝血因子VIII(FVIII)自身抗体中和引起的一种罕见的出血性疾病。本文主要针对AHA的诊断和治疗的相关内容提出指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 国际建议：获得性血友病A的诊断和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=456551c0019051ea, title=2020 国际建议：获得性血友病A的诊断和治疗, enTitle=International recommendations on the diagnosis and treatment of acquired hemophilia A., guiderFrom=Haematologica. 2020 May 7., authorId=0, author=, summary=获得性血友病A（AHA）是由抗凝血因子VIII(FVIII)自身抗体中和引起的一种罕见的出血性疾病。本文主要针对AHA的诊断和治疗的相关内容提出指导建议。, cover=https://img.medsci.cn/2020516/1589639003001_2020535.jpg, journalId=0, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Thu May 07 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>获得性血友病A（AHA）是由抗凝血因子VIII(FVIII)自身抗体中和引起的一种罕见的出血性疾病。本文主要针对AHA的诊断和治疗的相关内容提出指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1541, tagName=血友病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1541, guiderKeyword=血友病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3151, appHits=115, showAppHits=58, pcHits=720, showPcHits=3075, likes=0, shares=6, comments=4, approvalStatus=1, publishedTime=Sat May 16 22:37:48 CST 2020, publishedTimeString=2020-05-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 16 22:23:30 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:52:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 国际建议：获得性血友病A的诊断和治疗.pdf)])
2020 国际建议：获得性血友病A的诊断和治疗.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051629, encodeId=de94105162950, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c7f5291462, createdName=148645bdm06暂无昵称, createdTime=Wed Sep 15 20:47:31 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953019, encodeId=8ee1953019e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:23 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919706, encodeId=a207919e068b, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Mon Jan 25 14:54:25 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889098, encodeId=493d88909836, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57745264555, createdName=1480cb17m32暂无昵称, createdTime=Tue Sep 29 10:13:40 CST 2020, time=2020-09-29, status=1, ipAttribution=)]
    2021-09-15 148645bdm06暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051629, encodeId=de94105162950, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c7f5291462, createdName=148645bdm06暂无昵称, createdTime=Wed Sep 15 20:47:31 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953019, encodeId=8ee1953019e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:23 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919706, encodeId=a207919e068b, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Mon Jan 25 14:54:25 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889098, encodeId=493d88909836, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57745264555, createdName=1480cb17m32暂无昵称, createdTime=Tue Sep 29 10:13:40 CST 2020, time=2020-09-29, status=1, ipAttribution=)]
    2021-04-01 baijerrywu

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051629, encodeId=de94105162950, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c7f5291462, createdName=148645bdm06暂无昵称, createdTime=Wed Sep 15 20:47:31 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953019, encodeId=8ee1953019e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:23 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919706, encodeId=a207919e068b, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Mon Jan 25 14:54:25 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889098, encodeId=493d88909836, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57745264555, createdName=1480cb17m32暂无昵称, createdTime=Tue Sep 29 10:13:40 CST 2020, time=2020-09-29, status=1, ipAttribution=)]
    2021-01-25 LeoQ

    学习了学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051629, encodeId=de94105162950, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c7f5291462, createdName=148645bdm06暂无昵称, createdTime=Wed Sep 15 20:47:31 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953019, encodeId=8ee1953019e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:23 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919706, encodeId=a207919e068b, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Mon Jan 25 14:54:25 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889098, encodeId=493d88909836, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57745264555, createdName=1480cb17m32暂无昵称, createdTime=Tue Sep 29 10:13:40 CST 2020, time=2020-09-29, status=1, ipAttribution=)]
    2020-09-29 1480cb17m32暂无昵称

    学习了

    0

相关指南

2020 法国指南：血友病患者输注后因子VIII和IX监测

国外血液科相关专家小组 · 2020-04-10

2019 UKHCDO指南：艾美赛珠单抗治疗与实验室凝血检测

暂未更新 · 2019-12-20

2019 意大利共识：血友病患者的实验室检测

意大利血瘀血栓学会(SISET,Italian Society for Haemostasis and Thrombosis) · 2019-02-04

2018 专家共识：血友病患者早期肌肉骨骼疾病评估

国外血液科相关专家小组 · 2018-07-16

2018 血友病患者择期手术多学科管理建议

国外血液科相关专家小组 · 2018-06-26

浙江省血友病诊疗专家指导意见

浙江省医师协会血液科医师分会 · 2017-05-10

拓展阅读

2014 获得性血友病A诊断与治疗中国专家共识

中华医学会血液学分会血栓与止血学组 · 2014-06-15

MASAC建议：血友病患者的肝活组织检查（2013年）

国家血友病基金会医学科学咨询委员会(MASAC,Medical and Scientific Advisory Council of the National Hemophilia Foundation) · 2016-06-08

2015 UKHCDO指南：血友病临床遗传学服务

暂未更新 · 2015-05-01

【专题】 改善生命质量，携手对抗罕见病十周年：2.28国际罕见病指南合集

暂未更新 · 2017-02-28

中国儿童血友病专家指导意见（2017年）

中华医学会血液学分会血栓与止血学组 · 2017-01-30

《中国儿童血友病专家指导意见（2017年）》解读

暂未更新 · 2017-01-30